Anemias Archives | Report Store | Pharma intelligence

show blocks helper

Sort by Default

Display 15 Products per page

Market Spotlight: Chemotherapy-Induced Anemia

$1,318.00

This Market Spotlight report covers the chemotherapy-induced anemia market, comprising key marketed and pipeline drugs, clinical trials, regulatory events, probability of success, epidemiology information, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.
September 23, 2020
Find out more
Market Spotlight: Sickle Cell Anemia

$1,318.00

This Market Spotlight report covers the Sickle Cell Anemia market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming and regulatory events, probability of success, a 10-year disease prevalence forecast, and licensing and acquisition deals.
September 18, 2020
Find out more
Market Spotlight: Cold Agglutinin Disease

$1,318.00

This Market Spotlight report covers the Cold Agglutinin Disease market, comprising key pipeline drugs, clinical trials, probability of success, and an epidemiology overview.
August 20, 2020
Find out more
Disease Analysis: Anemia in Chronic Kidney Disease
Read More
Chronic kidney disease (CKD) is characterized by decreased kidney function and kidney damage. Damaged renal tissue has a diminished ability to produce erythropoietin, a hormone that stimulates red blood cell production.
July 23, 2020
Find out more
Chemotherapy-Induced Anemia Market and Forecast Analysis to 2027
Read More
Anemia is a common complication in cancer patients, and can arise due to the malignancy itself (cancer-related anemia), or chemotherapy treatment (chemotherapy-induced anemia [CIA]).
May 2, 2018
Find out more

Anemias

Market Spotlight: Chemotherapy-Induced Anemia

Market Spotlight: Sickle Cell Anemia

Market Spotlight: Cold Agglutinin Disease

Disease Analysis: Anemia in Chronic Kidney Disease

Chemotherapy-Induced Anemia Market and Forecast Analysis to 2027